Abstract:Self-assembly in living cells represents one versatile strategy for drug delivery; however, it suffers from the limited precision and efficiency. Inspired by viral traits, we here report a cascade targeting-hydrolysis-transformation (THT) assembly of glycosylated peptides in living cells holistically resembling viral infection for efficient cargo delivery and combined tumor therapy. We design a glycosylated peptide via incorporating a β-galactose-serine residue into bola-amphiphilic sequences. Co-assembling of the glycosylated peptide with two counterparts containing irinotecan (IRI) or ligand TSFAEYWNLLSP (PMI) results in formation of the glycosylated co-assemblies SgVEIP, which target cancer cells via β-galactose-galectin-1 association and undergo galactosidase-induced morphological transformation. While GSH-reduction causes release of IRI from the co-assemblies, the PMI moieties release p53 and facilitate cell death via binding with protein MDM2. Cellular experiments show membrane targeting, endo-/lysosome-mediated internalization and in situ formation of nanofibers in cytoplasm by SgVEIP. This cascade THT process enables efficient delivery of IRI and PMI into cancer cells secreting Gal-1 and overexpressing β-galactosidase. In vivo studies illustrate enhanced tumor accumulation and retention of the glycosylated co-assemblies, thereby suppressing tumor growth. Our findings demonstrate an in situ assembly strategy mimicking viral infection, thus providing a new route for drug delivery and cancer therapy in the future.

Self-assembly of Human Galectin-1 Via Dual Supramolecular Interactions and Its Inhibition of T-cell Agglutination and Apoptosis

Glyco-Platelets with Controlled Morphologies Via Crystallization-Driven Self-Assembly and Their Shape-Dependent Interplay with Macrophages.

Self‐Assembly of Glycolipid Epimers: Their Supramolecular Morphology Control and Immunoactivation Function

Cooperative, Reversible Self‐Assembly of Covalently Pre‐Linked Proteins into Giant Fibrous Structures

Precise and Reversible Protein-Microtubule-Like Structure with Helicity Driven by Dual Supramolecular Interactions.

Highly Ordered Self‐Assembly of Native Proteins into 1D, 2D, and 3D Structures Modulated by the Tether Length of Assembly‐Inducing Ligands

L-Rhamnose-containing Supramolecular Nanofibrils As Potential Immunosuppressive Materials.

Glycoconjugate nanoribbons from the self-assembly of carbohydrate-peptide block molecules for controllable bacterial cell cluster formation.

Tunable Bacterial Agglutination and Motility Inhibition by Self-Assembled Glyco-Nanoribbons

Supramolecular Self-Assemblies for Bacterial Cell Agglutination Driven by Directional Charge-Transfer Interactions.

Isomerization of proline-46 in the N-terminal tail of galectin-3 enhances T cell apoptosis via the ROS-ERK pathway

Hierarchical Self-Assembly of Native Protein and Its Dynamic Regulation Directed by Inducing Ligand with Oligosaccharide

Assembly of Glycopeptides in Living Cells Resembling Viral Infection for Cargo Delivery

Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions

Self-assembled Nanostructures of a Biomimetic Glycopolymer–polypeptide Triblock Copolymer

Dual molecular recognition leading to a protein-polymer conjugate and further self-assembly

Chemical Synthesis of Globo H and Mannobiose Glycopolymers and Their Immunological Stimulation

Building Nanowires from Micelles: Hierarchical Self-Assembly of Alternating Amphiphilic Glycopolypeptide Brushes with Pendants of High-Mannose Glycodendron and Oligophenylalanine.

An Antibody-like Polymeric Nanoparticle Removes Intratumoral Galectin-1 to Enhance Antitumor T-Cell Responses in Cancer Immunotherapy.

From polymer sequence control to protein recognition : synthesis, self-assembly and lectin binding

Altering the Modular Architecture of Galectins Affects its Binding with Synthetic α-Dystroglycan O-Mannosylated Core M1 Glycoconjugates In situ